Kimberly-Clark
KMB
Market cap $46.6B

140.56 USD

+0.95

0.68%

At close Mar 27, 4:00 PM EDT

Pre-market

140.56

+0.00

0.00%

1 day

0.68%

5 days

1.06%

1 month

0.26%

3 months

6.65%

6 months

-1.39%

Year to date

7.60%

1 year

10.44%

5 years

12.55%

10 years

32.14%

About: With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Employees: 38,000

Materials Converted Paper & Paperboard Products, Except Containers & Boxes

0

Funds holding %

of 7,390 funds

0

Analysts bullish %

of 8 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

57% more call options, than puts

Call options by funds: $241M | Put options by funds: $154M

45% more first-time investments, than exits

New positions opened: 188 | Existing positions closed: 130

2.61% more ownership

Funds ownership: 75.77% [Q3] → 78.38% (+2.61%) [Q4]

1% more funds holding

Funds holding: 1,711 [Q3] → 1,732 (+21) [Q4]

0% more capital invested

Capital invested by funds: $36.3B [Q3] → $36.3B (+$16.4M) [Q4]

8% less repeat investments, than reductions

Existing positions increased: 609 | Existing positions reduced: 662

33% less funds holding in top 10

Funds holding in top 10: 6 [Q3] → 4 (-2) [Q4]

See Fund Rankings

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$118

16%

downside

Avg. target

$140

1%

downside

High target

$165

17%

upside

8 analyst ratings

2 positive

25%

4 neutral

50%

2 negative

25%

Barclays Lauren Lieberman 44% 1-year accuracy 43 / 97 met price target	2%upside $144	Equal-Weight Maintained	27 Mar 2025
Piper Sandler Korinne Wolfmeyer 28% 1-year accuracy 13 / 47 met price target	12%upside $158	Overweight Reiterated	29 Jan 2025
UBS Peter Grom 48% 1-year accuracy 11 / 23 met price target	5%downside $134	Neutral Maintained	29 Jan 2025
RBC Capital Nik Modi 41% 1-year accuracy 16 / 39 met price target	17%upside $165	Outperform Reiterated	24 Jan 2025
JP Morgan Andrea Teixeira 41% 1-year accuracy 24 / 59 met price target	12%downside $124	Underweight Maintained	16 Jan 2025

See Analyst Rankings

Financial journalist opinion

Based on 15 articles about KMB published over the past 30 days

Kimberly-Clark: Streamlining Portfolio & Global Footprint; Initiate With 'Buy'

Kimberly-Clark has streamlined its portfolio and footprint, focusing on acquisitions and divestitures to accelerate organic revenue growth, earning a ‘Buy' rating with a fair value of $151 per share. The company's Integrated Margin Management approach has optimized expenses, expanded margins, and contributed to 3.2% organic revenue growth and 15.6% adjusted operating profit growth in FY24. Despite slow growth historically, strategic acquisitions like Thinx and divestitures like Neve tissue brand in Brazil support future above-market growth and portfolio optimization.

Kimberly-Clark: Streamlining Portfolio & Global Footprint; Initiate With 'Buy'

Zacks Investment Research

Zacks Industry Outlook The Procter & Gamble, Colgate-Palmolive, Kimberly-Clark and The Clorox

The Procter & Gamble, Colgate-Palmolive, Kimberly-Clark and The Clorox have been highlighted in this Industry Outlook article.

Zacks Industry Outlook The Procter & Gamble, Colgate-Palmolive, Kimberly-Clark and The Clorox

Zacks Investment Research

4 Consumer Product Stocks to Keep an Eye on Despite Market Challenges

The Zacks Consumer Products - Staples industry is navigating a tough consumer environment and elevated SG&A costs. Nevertheless, PG, CL, KMB and CLX are leveraging innovations to drive growth.

4 Consumer Product Stocks to Keep an Eye on Despite Market Challenges

My Favorite Stocks to Add Right Now

A friend of mine keeps posting every day about how much money she has lost in the stock market. I finally had to comment on her post: “Stop checking your account.

My Favorite Stocks to Add Right Now

Zacks Investment Research

KMB Trades Above 50 & 200-Day SMA: How Should Investors Play?

Kimberly-Clark is driving growth through innovation and market expansion while navigating economic pressures and currency headwinds.

KMB Trades Above 50 & 200-Day SMA: How Should Investors Play?

5 Recession-Proof Stocks To Consider As Economic Fears Grow

Uncertainty has taken over the market. Business and consumer sentiment data are souring as markets tumble and tariff policy continues to lack rhyme or reason.

5 Recession-Proof Stocks To Consider As Economic Fears Grow

5 Recession-Proof Stocks To Consider As Economic Fears Grow

Uncertainty has taken over the market. Business and consumer sentiment data are souring as markets tumble and tariff policy continues to lack rhyme or reason.

5 Recession-Proof Stocks To Consider As Economic Fears Grow

Kimberly-Clark Recognized as One of the 2025 World's Most Ethical Companies®

It is the seventh consecutive year the company has been named to the list, which honors organizations committed to business integrity through robust ethics, compliance, and governance programs. DALLAS , March 11, 2025 /PRNewswire/ -- Kimberly-Clark has received the 2025 World's Most Ethical Companies ® recognition by Ethisphere, a global leader in defining and advancing the standards of ethical business practices.

Kimberly-Clark Recognized as One of the 2025 World's Most Ethical Companies®

24/7 Wall Street

Americans Slash Spending: 5 High-Yield Dividend Consumer Staples Stocks Are Bulletproof

U.S. consumer spending collapsed in January, falling to lows not seen in almost four years.

Americans Slash Spending: 5 High-Yield Dividend Consumer Staples Stocks Are Bulletproof

10 Dividend Aristocrat Bargains To Help You SWAN During This Trade War Turmoil

The trade war is causing market volatility, with stocks falling and bonds performing well as investors seek hedges against economic slowdown fears. Dividend aristocrats, particularly low-volatility, defensive ones, offer a stable investment strategy during trade war turmoil. They provide dependable income and lower downside risk. The recommended 10 low volatility dividend aristocrats include Johnson & Johnson, PepsiCo, and Kimberly-Clark, offering a 4% yield and strong long-term return potential.

10 Dividend Aristocrat Bargains To Help You SWAN During This Trade War Turmoil

See News Rankings

Charts implemented using Lightweight Charts™